CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ecological governance.
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results